San Diego, CA, United States of America

Mark Charles Grier



 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mark Charles Grier: Innovator in Bicyclic Compounds

Introduction

Mark Charles Grier is a notable inventor based in San Diego, California. He has made significant contributions to the field of chemistry, particularly in the development of bicyclic compounds. With a total of two patents to his name, Grier's work focuses on innovative methods and applications that have the potential to impact the pharmaceutical industry.

Latest Patents

Grier's latest patents involve the synthesis and application of bicyclic compounds. These compounds are disclosed in Formulae (I) and (II), which detail methods of synthesizing these compounds and their use as analgesics. The innovative nature of his work lies in the potential therapeutic applications of these compounds, which could lead to advancements in pain management.

Career Highlights

Throughout his career, Mark Charles Grier has worked with various companies, including Zeno Royalties & Milestones, LLC and Recurium IP Holdings, LLC. His experience in these organizations has allowed him to refine his expertise in intellectual property and innovation in the chemical sector.

Collaborations

Grier has collaborated with notable professionals in his field, including Kevin Duane Bunker and Chuangxing Guo. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Mark Charles Grier is a distinguished inventor whose work in bicyclic compounds showcases his commitment to innovation in the pharmaceutical field. His contributions have the potential to lead to significant advancements in pain management therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…